-
The price regulation of pharmaceuticals is illusory
02.09.2020The Competition Authority conducted an analysis of the competition situation in order to assess the functioning of the regulation that sets the limits for the prices of medicines. The Competition Authority considers that the current system for the mark-up of medicines is deficient and its supervision is fragmented. As a result, there is a significant risk of non-compliance with the set rules.
-
Competition Authority initiated proceedings in connection with a power failure in Narva, Narva-Jõesuu and Sillamäe
20.05.2019On May 20, the Competition Authority initiated supervision proceedings against Elering AS in connection with the power failure on May 18 in Narva, Narva-Jõesuu and Sillamäe.
The purpose of the proceedings is to identify the reasons for the power failure and whether there may be a violation of the Electricity Market Act. -
The price regulation of pharmaceuticals is illusory
02.09.2020The Competition Authority conducted an analysis of the competition situation in order to assess the functioning of the regulation that sets the limits for the prices of medicines. The Competition Authority considers that the current system for the mark-up of medicines is deficient and its supervision is fragmented. As a result, there is a significant risk of non-compliance with the set rules.
Quick Links
Latest updates
- Annual report 2019 » (645.25 KB, PDF)
- Electricity and Gas Market Report 2018 » (2.58 MB, PDF)
- Manual to Calculate Weighted Average Cost of Capital » (875.52 KB, PDF)
Contacts ENG
Estonian area code +372
| 667 2400 | General info |
| 667 2420 | Press Contact |
| 667 2440 | Competition Division |
| 667 2576 | Regulatory Division |
| Tatari 39, Tallinn 10134 ESTONIA info@konkurentsiamet.ee |
|
| Please contact for appointments Monday-Friday 8.30-16.30 |
Energy metering data
